AxoGen, Inc.
AXGN
$14.84
-$1.43-8.76%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 18.26% | 17.36% | 15.10% | 17.86% | 25.57% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 18.26% | 17.36% | 15.10% | 17.86% | 25.57% |
Cost of Revenue | 16.53% | 55.59% | 8.52% | 27.58% | 47.79% |
Gross Profit | 18.88% | 7.09% | 17.34% | 14.93% | 19.20% |
SG&A Expenses | 15.04% | 2.46% | 2.90% | 2.49% | -1.00% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 13.76% | 9.32% | 2.76% | 8.09% | 7.29% |
Operating Income | 490.65% | 63.57% | 163.15% | 92.15% | 93.80% |
Income Before Tax | 130.14% | 42.22% | 111.56% | 54.56% | 71.16% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 130.14% | 42.22% | 111.56% | 54.56% | 71.16% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 130.14% | 42.22% | 111.56% | 54.56% | 71.16% |
EBIT | 490.65% | 63.57% | 163.15% | 92.15% | 93.80% |
EBITDA | 160.15% | 104.50% | 335.76% | 150.05% | 121.63% |
EPS Basic | 128.70% | 44.76% | 111.06% | 55.47% | 71.75% |
Normalized Basic EPS | 128.73% | 44.73% | 111.15% | 55.39% | 71.68% |
EPS Diluted | 122.78% | 44.76% | 111.06% | 57.70% | 72.56% |
Normalized Diluted EPS | 127.27% | 44.73% | 110.44% | 55.39% | 71.68% |
Average Basic Shares Outstanding | 5.38% | 4.56% | 4.24% | 2.00% | 1.99% |
Average Diluted Shares Outstanding | 9.76% | 4.56% | 11.65% | 2.00% | 1.99% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |